Journal Title
Cancers

CANCERS

ISSN / eISSN
2072-6694
Aims and Scope
Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
Subject Area

ONCOLOGY

CiteScore
7.40 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Oncology Q1 #90/366
Medicine - Cancer Research Q2 #82/214
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
ONCOLOGY - SCIE Q2
H-index
53
Country/Area of Publication
Switzerland
Publisher
MDPI (Basel, Switzerland)
Year Publication Started
2009
Annual Article Volume
6140
Open Access
YES
Contact
ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Male tumor, almost all figures were done by bioinformatics, except for one dual staining of fluorescent mice tumor. It is a special project!

Uploaded on 2022.02.28
Received first peer review results on 2022.03.18. Two reviewers, one requested major revisions of experiments, and the other requested minor revisions. The editor gave us 10 days for major revisions, but due to some unexpected delays, we lost two days. Additionally, we had already started working on further projects and did not want to include the new images in the old article, so we rejected the request to add experiments, causing a delay in the submission. The reviewer's comments on major revisions were 7 pages long, while the reviewer for minor revisions had only 5 lines of questions, with three lines related to citations.

Received the second peer review results on 2022.03.29. The reviewer for major revisions still requested additional experiments, while the reviewer for minor revisions did not provide any comments. We were given 5 days for minor revisions. We added a relatively inferior figure. The reviewer for major revisions did not mention any language issues in the first review, but in the second review, they asked us to improve the language. However, our corresponding author is from Norway, and the second author is from the UK...

Accepted on 2022.04.06

Reviewer fee: 2400 CHF, approximately equivalent to around 17000 RMB at the exchange rate.
2022-04-06
How long does it take to have results under review? (What is the whole process like, can you please explain? Thank you)
2022-08-16

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now